Skip to content

Archives

March 25, 2024 Key Moments from Ways and Means Hearing with Social Security Commissioner Martin O’Malley

WASHINGTON, D.C. – Ways and Means Committee Republicans secured a number of commitments from Social Security Commissioner Martin O’Malley to make reforms…

Read More (Key Moments from Ways and Means Hearing with Social Security Commissioner Martin O’Malley)
March 23, 2024 Seven Key Moments from Ways and Means Hearing with Health and Human Services Secretary Xavier Becerra

WASHINGTON, D.C. – The Ways and Means Committee held Health and Human Services (HHS) Secretary Xavier Becerra accountable for playing politics…

Read More (Seven Key Moments from Ways and Means Hearing with Health and Human Services Secretary Xavier Becerra)
February 06, 2024 Chairman Smith Opening Statement – Hearing on Chronic Drug Shortages

“It’s clear to me that we need to incentivize the development of higher quality drugs and improve purchasing dynamics without…

Read More (Chairman Smith Opening Statement – Hearing on Chronic Drug Shortages)
August 29, 2023 Fact Sheet: Democrats’ Drug Price-Setting Scheme Dismantles Medicare’s Promise, Undermines Seniors’ Health

The Biden Administration has announced the first 10 medications under its new Medicare price-setting plan for prescription drugs that was…

Read More (Fact Sheet: Democrats’ Drug Price-Setting Scheme Dismantles Medicare’s Promise, Undermines Seniors’ Health)
May 12, 2023 Five Key Moments from Health Subcommittee Hearing on Medical Innovation and Access to Care

On Wednesday, the House Ways and Means Subcommittee on Health held a hearing examining policies that inhibit medical innovation and…

Read More (Five Key Moments from Health Subcommittee Hearing on Medical Innovation and Access to Care)
April 12, 2023 Congressional Republicans Call for Reconsideration of Administration’s Anti-Innovation Drug-Price Policy

WASHINGTON, DC —Patients, caregivers, and practitioners will soon see fewer cures should the Biden Administration move forward with implementing its…

Read More (Congressional Republicans Call for Reconsideration of Administration’s Anti-Innovation Drug-Price Policy)